Search Results 731-740 of 13490 for monoclonal antibody
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...
As are the outpatient therapies, such as the monoclonal antibody treatments, Mayo Clinic is offering to help keep patients out of the hospitals. "We still ...
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
Developing novel targeted therapies including humanized monoclonal antibody and antibody drug conjugate to target AXL receptor tyrosine kinase for triple ...
Monoclonal antibodies, such as ganitumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
And the Food and Drug Administration has approved monoclonal antibody therapies Inmazeb and Ebanga to treat Ebola. Therapy. Supportive care may help you feel ...
An FGF23 monoclonal antibody (burosumab) was recently approved by the U.S. Food and Drug Administration for use in patients in whom surgical tumor resection ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.